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730 The Journal of Thoracic and CardioBackground: In patients with Marfan
syndrome, progressive aortic dilation
implicates a still-unpredictable risk of
life-threatening aortic dissection and
rupture. We sought to quantify aortic
wall dysfunction noninvasively, deter-
mine the diagnostic power of various
aortic parameters, and establish a diagnostic model for the early detection of aortic abnor-
malities associated with Marfan syndrome.
Methods: In 19 patients with Marfan syndrome (age, 17.7  9.5 years) and 19 age-
and sex-matched healthy control subjects, computerized ascending and abdominal aortic
wall contour analysis with continuous determination of aortic diameters was performed out
of transthoracic M-mode echocardiographic tracings. After simultaneous oscillometric blood
pressure measurement, aortic elastic properties were determined automatically.
Results: The following ascending aortic elastic parameters showed statistically signif-
icant differences between the Marfan group and the control group: (1) decreased aortic
distensibility (P  .001), (2) increased wall stiffness index (P  .01), (3) decreased
systolic diameter increase (P .01), and (4) decreased maximum systolic area increase
(P  .001). The diagnostic power of all investigated parameters was tested by single
logistic regression models. A multiple logistic regression model including solely aortic
parameters yielded a sensitivity of 95% and a specificity of 100%.
Conclusions: In young patients with Marfan syndrome, a computerized image-analyz-
ing technique revealed decreased aortic elastic properties expressed by parameters
showing high diagnostic power. A multiple logistic regression model including merely
aortic parameters can serve as useful predictor for Marfan syndrome.
Marfan syndrome (MFS; Online Mendelian Inheritance in Man#154700) is an autosomal dominant connective tissue disor-der caused by mutations in the gene encoding fibrillin-1(FBN1), with highly variable clinical manifestations in themusculoskeletal, ocular, and cardiovascular systems.1,2 Dila-tation of the aortic root predisposes the subject to aortic
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Frischhut, Hess, Hammererdissection and rupture or severe regurgit
vascular Surgery ● April 2005ation and heart failure.3 Diseases of the
Baumgartner et al Surgery for Congenital Heart Disease
CH
Daorta account for 80% of known causes of death.3 Before
life-threatening complications, alterations of aortic elastic
properties due to defective FBN1 can be characterized by
the terms of elasticity or compliance, distensibility, stiffness
index, and pulse wave velocity.4-7
The aim of this study was to investigate aortic elasticity
and assess its abnormality in patients with MFS by means of
a standardized, semiautomated, and noninvasive method.
This technique is appropriate for determining the course of
aortic elasticity during follow-up investigations. All aortic
parameters were implemented in single logistic regression
models to test their diagnostic power. To further increase
sensitivity and specificity, we searched for a multiple logis-
tic regression model able to serve as an appropriate diag-
nostic marker for MFS. To localize aortic elastic dysfunc-
tion, we suggest visualization of ascending (AscAo) and
descending aortic (DescAo) diameter changes by a vector
loop.
Methods
Patients and Control Subjects
Forty-seven people with suspected MFS were investigated at the
Departments of Pediatric Cardiology, Ophthalmology, and Ortho-
pedics and at the Institute of Medical Biology and Human Genet-
ics, Innsbruck Medical University, according to a standardized
protocol. Nineteen of these, whose diseases were diagnosed as
MFS according to the Ghent criteria8 and who were younger than
40 years, comprised the study group (3 males and 16 females;
mean age, 17.7  9.5 years). Clinical characteristics are shown in
Tables 1 and 2. Physical features were documented according to
the consensus of 2 physicians (D.B. and J.L.-R.). Before the
investigation, no patient received a -blocker, angiotensin-con-
verting enzyme inhibitor, or calcium antagonist or had a history of
aortic dissection or aortic surgery. Nineteen age- and sex-matched
healthy subjects constituted the control group. Two of them were
healthy relatives of patients with MFS. A group of 35 people
totally different from the study population, including 16 patients
with MFS and 19 healthy controls, served as validation group for
the logistic regression analysis. The mean age of this group was
14.2  8.0 years and ranged from 0 to 36 years. The study
complied with the Declaration of Helsinki. The protocol was
approved by the institutional committee on human research. All
subjects gave informed consent.
Molecular Genetic Analysis
Mutation analysis of the FBN1 gene was performed in all 19 MFS
patients as described.9 In brief, genomic DNA samples were
amplified exon by exon by means of polymerase chain reaction
(PCR) by using intron-specific primers. All 65 amplicons were
analyzed by denaturing high-performance liquid chromatography
followed by direct sequencing of amplicons with abnormal elution
profiles. The mutations found were verified by repeated sequenc-
ing on newly amplified PCR products. In the case of splice site
mutations and when no mutation was detected by denaturing
high-performance liquid chromatography, FBN1 transcripts were
The Journal of Thoracianalyzed by reverse transcription-PCR of RNA templates isolated
from fibroblasts.
Echocardiographic Evaluation
All echocardiographic examinations were performed by 1 investi-
gator (D.B.) in the left decubitus position with commercially
available equipment (System Five; GE Vingmed Ultrasound,
Horten, Norway). M-mode tracings of the aorta were obtained
according to published criteria10 by using 2-dimensional guidance
at 4 different levels: level 1, annulus (parasternal short-axis view);
level 2, sinuses of Valsalva; level 3, proximal AscAo 10 to 20 mm
distal to the sinotubular junction (both parasternal long-axis
views); and level 4, descending abdominal aorta just proximal to
the branching off of the celiac trunk (abdominal paramedian long-
axis view). Attention was paid to setting the line of sight exactly
perpendicular to the long axis of the aorta in views showing the
largest aortic diameters. Sharp endothelial lines were used as
additional indicators for the line of sight to cut the central line of
the aorta. Aortic dilatation was determined with standard nomo-
grams.10
For automated and standardized calculation of aortic diameters,
we developed suitable software. First, M-mode tracings of the
AscAo (level 3) and DescAo (level 4) of at least 5 heart cycles
were loaded into the program. To find the inner aortic wall con-
tours, an image-processing algorithm ran on the M-mode images.
Out of the determined aortic edge map, AscAo and DescAo
outlines were calculated throughout the heart cycles (Figure 1,
left). In some images with a suboptimal signal-to-noise ratio,
minor manual corrections of aortic wall contours had to be per-
formed. Interobserver reproducibility, calculated as the standard
deviation of the differences between measurements and expressed
as the percentage of the mean of the measurements, was deter-
mined after re-evaluation of randomly selected images by a second
investigator blinded to the initial results. According to the usual
aortic diameter measurements with the leading edge technique,10
the automatically detected inner diameter of the aorta was enlarged
by the anterior aortic wall thickness. Time-diameter curves of 5
heart cycles were generated, based on the aortic wall contours.
They showed a time resolution of approximately 6 ms per pixel
and a spatial resolution of 0.2 mm per pixel. The curves were
averaged and slightly smoothed by a digital low-pass filter (But-
terworth; degree 2) to eliminate the digitalization noise (Figure 1,
right). Out of time-diameter curves and averaged threefold blood
pressure measurements, which were taken at the right arm oscil-
lometrically (Dinamap; GE Healthcare, Slough, United Kingdom)
immediately before M-mode registration, aortic elastic parameters
were estimated automatically.
Calculation of Aortic Parameters
In addition to established aortic elastic parameters such as aortic
distensibility and wall stiffness index,6,11 we developed maximum
systolic area increase (MSAI), a parameter that is advantageous
because of its easy determination. Aortic integral ratio and vec-
toraortography indicate the region of reduced aortic elasticity. The
parameters were defined as follows.Systolic diameter increase was calculated as
c and Cardiovascular Surgery ● Volume 129, Number 4 731
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D(DsDd) ⁄ Dd (%), (1)
where Ds is systolic (maximum) and Dd is end-diastolic (mini-
mum) aortic diameter. Cross-sectional (CS) aortic distensibility
and stiffness index were estimated as previously described6,11:
Distensibilty
AsAd
Ad · (Ps Pd) · 1333
· 107(kPa1 · 103) (2)
Stiffness index
In(Ps ⁄ Pd)
(DsDd) ⁄ Dd
(dimensionless), (3)
TABLE 1. Aortic parameters and FBN1 gene mutations in
Patient No.
Age
(y) Sex BSA (m2) Mutation
Aortic
diast
diamete
dilate
1* 2 F 0.59 344CG; S115C§ 20
2 2 F 0.63 1206delT; frameshift
 PTC
21
3† 9 F 1.20 508delT; frameshift 
PTC
27
4† 10 F 1.21 508delT; frameshift 
PTC
28
5‡ 11 F 1.51 7801CT; Q2601X 31
6‡ 12 F 1.78 7801CT; Q2601X 37
7 12 F 1.40 1453CT; R485C 27
8‡ 15 F 1.95 7801CT; Q2601X 33
9† 16 F 1.63 508delT; frameshift 
PTC
32
10 16 M 1.81 No FBN1 mutation
detected
34
11 17 M 1.87 IVS142AG 36
12 18 F 1.87 IVS45  3insCC¶ 44
13 18 M 1.87 3194delAAAG;
frameshift  PTC
42
14 22 F 1.63 4337delATA;
D1446_I1447delinsV
50
15 23 F 1.81 651GA; W217X 36
16 25 F 1.88 6794GA; C2265Y 36
17 30 F 1.76 2638GA; G880S 51
18* 30 F 1.85 344CG; S115C§ 32
19‡ 40 F 2.02 7801CT; Q2601X 42
Patients
Mean 17.7 1.56 34.7 n
SD 9.5 0.43 8.5
Controls
Mean 17.6 1.44 24.6
SD 9.9 0.39 4.6
P value NS NS .001
BSA, Body surface area; AscAo, ascending aortic; DescAo, descending
significant, , Dilated; , not dilated.
*, †, and ‡ indicate the members of family 1, 2 and 3.
§Patients 1 and 18 carry a published mutation.29
Cryptic splice site in intron 14 and insertion of 18 bp in frame.
¶Deletion of exon 45 in frame.where As is systolic and Ad is end-diastolic area and Ps is systolic
732 The Journal of Thoracic and Cardiovascular Surgery ● Apriand Pd is diastolic blood pressure (mm Hg). Area A was deter-
mined as (D/2)2 · .
MSAI was defined as the maximum systolic slope of the
area-time curve A(t) normalized to Ad:
MSAI
d
dtA(t) ⁄ Ad 1 · 100max (%/100 ms) (4)
Integrals of the AscAo and DescAo area-time curves normalized to
the corresponding end-diastolic area—defined as aortic integral
ratios—show in which aortic segment elasticity is reduced more
tients with Marfan syndrome
,
AscAo
diastolic
diameter (mm,
dilated)
DescAo
diastolic
diameter
(mm)
Systolic
blood
pressure
(mm Hg)
Pulse
pressure
(mm Hg)
Distensibility
(kPa1 · 103)
AscAo DescAo
14.4  5.2 90 38 39 79
15.4  7.7 106 60 21 36
18.5  12.1 111 58 70 56
20.1  12.3 96 57 24 40
21.2  12.7 118 47 43 44
22.8  11.5 122 46 61 72
24.1  12.2 116 55 38 34
28.2  11.8 116 55 22 48
26.5  12.1 117 48 35 73
23.1  10.9 116 54 21 76
25.8  17.4 117 61 20 35
41.5  14.4 113 48 0 37
31.9  15.0 137 62 0 48
34.2  14.1 111 33 0 31
24.8  14.6 130 50 30 9
27.3  17.3 120 64 67 14
42.6  17.4 116 47 27 41
28.7  12.7 129 46 0 35
27.7  15.5 131 57 25 13
7 26.2 n  8 13.0 116 52 29 43
7.5 42% 3.1 11 8 21 21
0 20.6 n  1 12.0 116 49 62 65
4.0 5% 2.6 8 9 24 30
.007 NS NS NS 0.001 0.013
ic; PTC, premature termination codon; SD, standard deviation; NS, not19 pa
root
olic
r (mm
d)



















 1
89%
n 
aortseverely.
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DAortic integral ratio

HC
A(t) ⁄ AdAscAodt

HC
A(t) ⁄ AdDescAodt
, (5)
where A(t) the is aortic area-time curve and HC is the heart cycle.
The vectoraortography visualizes the vector loop of the relative
AscAo and DescAo diameter changes during the heart cycle. The
rotating vector can be characterized by its magnitude and phase:
Magnitude(t)
(D(t) ⁄ Dd 1) · 100AscAo2  (D(t) ⁄ Dd 1) · 100DescAo2 (%)
(6)
Phase(t) arctanD(t) ⁄ Dd 1DescAoD(t) ⁄ Dd 1AscAo 	 (degree), (7)
where D(t) is the aortic diameter-time curve.
Statistics
Data are expressed as mean  SD and, in Figure 2, A as mean  95%
confidence interval. Quantitative variables were compared by means
of unpaired Student t tests and Mann-Whitney U tests, respectively.
The relation between continuous variables was tested by linear re-
gression analysis. Single and multiple logistic regression models were
TABLE 2. Cardiovascular parameters in patients with Mar
Parameters
Heart rate (beats/min)
Systolic blood pressure (mm Hg) 1
Diastolic blood pressure (mm Hg)
Pulse pressure (mm Hg)
Bulbus aortae
Diastolic diameter (mm) 3
Normalized diastolic diameter (mm/m2) 2
Ascending aorta
Diastolic diameter (mm) 2
Normalized diastolic diameter (mm/m2) 1
Systolic diameter increase (%)
Distensibility (kPa1 · 103)
Stiffness index
Maximum systolic area increase (%/100 ms)
Descending aorta
Diastolic diameter (mm) 1
Normalized diastolic diameter (mm/m2)
Systolic diameter increase (%) 1
Distensibility (kPa1 · 103)
Stiffness index
Maximum systolic area increase (%/100 ms)
Vectoraortography
Magnitude (%) 1
Phase (degree)
Aortic integral ratio
Values are shown as mean  SD; NS, Not significant (P  .05); normalizdeveloped to estimate the diagnostic power of the aortic parameters.
The Journal of ThoraciThe conditional probability for the presence of MFS is denoted by the
equation PMFS 1 1⁄1 exp z where z indicates the logit
of the model. The effect of each model parameter is given by its odds
ratio. All statistical analyses were performed with the software pack-
age SPSS 11.0 (SPSS Inc, Chicago, Ill).
Results
Clinical Characteristics
Clinical characteristics of the Marfan patients and control
persons were compared in Tables 1 and 2. Age, sex, weight,
height, body-surface area, and heart rate did not differ
between Marfan patients and control persons. Four patients
(21%) presented with mild aortic regurgitation (1), 16
(84%) presented with mitral valve prolapse, and 16 (84%)
presented with mitral regurgitation (7 with 1, 8 with 2,
and 1 with 3) as defined by Doppler echocardiography.
Seventeen patients (90%) showed skeletal symptoms of
MFS; in 6 (32%) of them the skeleton was involved, and 11
(58%) fulfilled the major skeletal criteria according to the
Ghent nosology.8 Ectopia lentis was present in 10 patients
(53%), and 11 patients (58%) had a family history of MFS.
Results of FBN1 gene mutation analysis are presented in
yndrome (MFS) and in control subjects
S
19)
Control subjects
(n  19) P value
19 73 14 NS
11 116 8 NS
12 68 10 NS
8 49  9 NS
8.5 24.6 4.6 .001
5.1 18.0 4.0 .002
7.5 20.6 4.0 .007
4.1 15.2 3.4 NS
10.6 18.0 6.1 .001
21 62 24 .001
2.6 3.4  1.4 .001
19 55 21 .001
3.1 12.0 2.6 NS
1.6 8.8  2.2 NS
5.9 18.6 6.1 .014
21 65 30 .013
3.9 3.2  1.0 .009
17 54 21 .044
6.2 25.4 7.2 .002
41 47 11 NS
2.1 1.1  0.5 NS
stolic diameter means diastolic diameter divided by body surface area.fan s
MF
(n 
71
16
65
52
4.7
2.9
6.2
7.0
7.5
29 
6.2
28
3.0
8.4 
3.6
43 
5.8
41
8.2
66
1.1Table 1.
c and Cardiovascular Surgery ● Volume 129, Number 4 733
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DAortic Dimensions and Calculation of Elastic
Parameters
Echocardiographic aortic findings of the Marfan group and
the control group are shown in Tables 1 and 2. Diastolic
aortic root (P  .001) and diastolic AscAo diameter (P 
.007) were significantly increased in the MFS group,
whereas the difference of DescAo diameters between
groups did not reach statistical significance. All 4 investi-
gated elastic parameters demonstrated reduced aortic elastic
properties in MFS patients (Table 2 and Figure 2): AscAo
systolic diameter increase (42% of control group), CS dis-
tensibility (47%), and MSAI (51%) were significantly di-
minished in the Marfan group. The stiffness index, as being
inversely related to distensibility, was markedly increased
(182% of control group). Four MFS patients (patients 12-14
Figure 1. Semiautomated aortic wall contour analysis
and descending (bottom left) aorta of patient 5. Arrows
time-diameter curves of the ascending (top right) andand 18; Table 1) revealed an AscAo diameter decrease
734 The Journal of Thoracic and Cardiovascular Surgery ● Apriduring systole; in these cases, CS distensibility and MSAI
were set to 0, and stiffness index could not be calculated.
Note that both patients without aortic root dilatation (pa-
tients 7 and 18; Table 1) showed a decreased AscAo dis-
tensibility and a reduced DescAo distensibility of1 SD. In
the DescAo of MFS patients, we observed less systolic
diameter increase, CS distensibility, and MSAI; the stiffness
index was markedly greater than in the control group. The
differences were smaller than in the AscAo (Table 2). In 3
of 5 adult MFS patients, in whom elective prosthetic aortic
root replacement was indicated at or 1 year after the initial
investigation (patients 12, 14, and 17 out of the study group
[Table 1] and 2 patients out of the validation group), AscAo
distensibility and MSAI were 0. Because of systolic diam-
eter decrease, aortic stiffness index could not be calculated.
te lines) in M-mode images of the ascending (top left)
cate the beginning and end of 1 heart cycle. Averaged
ending (bottom right) aorta are shown.(whi
indiIn the remaining 2 of the 5 operated patients, AscAo dis-
l 2005
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Dtensibility was strongly decreased (12 and 27 kPa1 · 103).
However, 1 MFS patient (patient 18) showed an AscAo 0
Figure 2. Vectoraortography. A, Vector loops represent
diameter changes (D(t)/Dd) during the heart cycle. The 9
by thin lines. The loop of the Marfan (MFS) patients is
This shows the reduction of aortic elasticity predomina
the vectors’ maximum magnitude in the MFS and the co
lengths of individuals. Beyond 600 ms cycle length, da
4 subgroups according to the aortic integral ratio. The
control group are shown. *, †, and ‡ indicate the memdistensibility without aortic root dilatation.
The Journal of ThoraciAscAo and DescAo CS distensibility were greater in
young patients and control persons (age, 2-12 years; n  7)
ive ascending (AscAo) and descending (DescAo) aortic
onfidence interval at 0, 200, 400, and 600 ms is denoted
ller and a little steeper than that of the control group.
present in the AscAo of MFS patients. Arrows indicate
groups. Loops are not closed because of varying cycle
ere not included. B, The MFS group was divided into
rs of the total MFS group, the MFS subgroups, and the
of family 1, 2, and 3 (Table 1).relat
5% c
sma
ntly
ntrol
ta wthan in older ones (age, 15-19 years; n  6; and age, 20-42
c and Cardiovascular Surgery ● Volume 129, Number 4 735
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Dyears; n  6), although no strong linear correlation between
age and distensibility could be found (r  0.8). In MFS
patients, the differences between age groups were less pro-
nounced than in controls.
CS distensibility and MSAI values of the AscAo and Des-
cAo of Marfan patients and control persons correlated signif-
icantly (MSAI 0.68 CS distensibility 10.54; r 0.86;
P  .01).
Interobserver reproducibility, which was determined in 6
consecutive patients, was 2.6% and 3.3% for AscAo and
DescAo diastolic diameter measurements and was 3.8% and
4.6% for AscAo and DescAo distensibility. Reproducibility
of further aortic elastic parameters showed comparable val-
ues.
Aortic Integral Ratio
Mean values of the AscAo/DescAo integral ratio were sim-
ilar between Marfan patients and control persons, but in the
MFS group, the standard deviation was markedly increased
(1.1  2.1 in the MFS vs 1.1  0.5 in the control group;
Table 2). This ratio showed the variable extent of regional
aortic elasticity alterations in the Marfan patients and, con-
versely, a tight relationship of AscAo and DescAo integrals
in healthy control subjects.
Vectoraortography
The vector loops characterizing the relative aortic diameter
changes during the heart cycle differed significantly be-
tween the MFS and the control group (Figure 2, A and Table
2). The maximum magnitude of the vector (Figure 2, A) was
significantly reduced in the MFS group, and the vector’s
phase at maximum magnitude (ie, the angle below the
vector) showed no significant difference between groups (P
 .061). Because of the high standard deviation of the phase
and aortic integral ratio in the MFS group, we split the
Marfan patients into 4 subgroups to distinguish among
different elasticity patterns (Figure 2, B). In the first sub-
group, the AscAo diameter decreased during early systole,
so that phase was strongly increased (mean, 131°). In sub-
group 2, phase was also increased, but AscAo diameter
increased during systole. Subgroup 3 (aortic integral ratio,
0.6-1.6; ie, mean value  1 SD of control group) showed a
mean phase (54°) roughly comparable to the control group
because of similar reduction of AscAo and DescAo pulsatile
diameter changes. In subgroup 4, phase was strongly re-
duced (mean 10°) because of decreased pulsatile diameter
changes predominantly in the DescAo.
Single and Multiple Logistic Regression Analysis
All presented aortic parameters were tested separately for
their diagnostic power by single logistic regression analysis
(Table 3). AscAo distensibility and systolic diameter in-
crease demonstrated the highest sensitivity (84%); the dia-
736 The Journal of Thoracic and Cardiovascular Surgery ● Apristolic diameter of the bulbus aortae normalized to body-
surface area showed the highest specificity (84%).
To increase the diagnostic power of the classification
models, we searched for the multiple logistic regression
model z displaying the highest sensitivity (94.7%) and spec-
ificity (100%). The logit of the regression model is given by
the following equation:
z 4.379 2.293 · normalized BA diastolic diameter
 2.449 · normalized AscAo diastolic diameter
 0.247 · AscAo distensibility
(P  .030; P  .028; P  .035; odds ratios: 9.901, 0.086,
and 0.781; Table 3)
Subsequently, our best model z was tested on the inde-
pendent validation group and showed a sensitivity of 100%
and a specificity of 94.7%. Validation of the single logistic
regression models also yielded comparable results to those
established in the study population.
Discussion
Our new noninvasive semiautomated M-mode echocardio-
graphic image-segmentation technique showed reduced aor-
tic elastic properties in children and young adults with MFS,
with high accuracy and objectivity. In most published stud-
ies, aortic diameters and CS areas, which underlie the cal-
culation of aortic elastic properties, still rely on a slow,
tedious, and observer-dependent process of manual outlin-
ing, which has to be performed by expert physicians.
In adults with MFS, automated border detection has been
used to measure aortic diameters out of transesophageal
aortic images.12 We used 2-dimensional guided transtho-
racic M-mode echocardiographic aortic diameter measure-
ments, which showed good correlation with 2-dimensional
echocardiographically obtained values.10 Two-dimensional
guidance is indispensable for correct diameter measure-
ments out of M-mode echocardiographic images, especially
for displaying the largest aortic diameter and for finding an
axis strictly perpendicular to the long axis of the aorta.10 In
contrast to continuous aortic measurements out of 2-
dimensional echocardiographic or magnetic resonance im-
aging sequences, M-mode echocardiography enables us to
measure aortic diameters over 5 heart cycles with twofold to
fivefold higher time resolution out of merely 1 to 2 images.
In children and young adults, images of high quality can be
obtained in most cases. However, accurate image acquisi-
tion with a high signal-to-noise ratio is essential for appro-
priate computerized contour finding.
Aortic root dilatation, a major criterion of MFS,8 was
shown to be present in 89% of our patients and was reported
in 61.5% to 84% of adults1,13-16 and in 42.5% to 76% of
children aged 0.25 to 18 years.15,17 AscAo dilatation was
present in 42% of our patients and has been reported in 54%
of adults15 and in 45% of children (age, 0.5-18 years).15
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DBecause aortic dilatation evolves during childhood and ad-
olescence, serial evaluations of aortic dimensions may be
necessary to clearly demonstrate the presence and progres-
sion of aortic dilatation.18 Because aortic root growth is of
prognostic value for the occurrence of aortic complica-
tions,18 objective diameter measurements will enhance the
accuracy of results.
The representation of time-diameter curves gives us an
optical impression of aortic diameter changes during the
heart cycle (Figure 1, right). The vectoraortography—a
compaction of time-diameter relations of 2 aortic segments
in 1 diagram—and the aortic integral ratio allow us to
distinguish different patterns of aortic stiffening within the
MFS group (Figure 2). In 4 patients with considerable aortic
root dilatation, the AscAo anteroposterior diameter de-
creased during systole, which—to our knowledge—has
never been described before (patients 12-14 and 18; mean
end-diastolic aortic root diameter, 42.0 7.5 mm vs 34.9
8.6 mm in the total MFS group; mean end-diastolic AscAo
diameter, 34.0  5.4 mm vs 26.2  7.5 mm in the total
MFS group; Figure 2, B, subgroup 1). As we observed by
echocardiography in a few patients with excellent quality of
AscAo 2-dimensional images, the AscAo seemed to bump
against an anterior structure (probably the sternum) during
TABLE 3. Predictive power of single and multiple logistic
Cardiovascular parameters
Single logistic models
Bulbus aortae (BA)
Normalized diastolic diameter (mm/m2)
Ascending aorta (AscAo)
Normalized diastolic diameter (mm/m2)
Systolic diameter increase (%)
Distensibility (kPa1 · 103)
Stiffness index
Maximum systolic area increase (MSAI) (%/100 ms)
Descending aorta (DescAo)
Normalized diastolic diameter (mm/m2)
Systolic diameter increase (%)
Distensibility (kPa1 · 103)
Stiffness index
Maximum systolic area increase (MSAI) (%/100 ms)
Vectoraortography
Magnitude (%)
Phase (degree)
Aortic integral ratio
Multiple logistic model (best model)
Normalized BA diastolic diameter; normalized AscAo diastolic
AscAo distensibility
The diagnostic performance of the models is indicated by their sensitiv
parameter(s). AscAo and DesAo diastolic diameters were normalized to bits systolic anterior movement; the aortic CS area for a short
The Journal of Thoracitime deviated from its circular shape toward an elliptic
shape. Therefore, the aortic wall of these patients is exposed
to increased shear stress. AscAo distensibility and MSAI
were set to 0, and AscAo stiffness index could not be
calculated. Patients with predominant loss of DescAo elas-
ticity (subgroup 4) may resemble those who are at risk for
aneurysm or dissection of the DescAo.19,20 Our technique
can thus serve as a valuable noninvasive tool for assessing
the descending abdominal aorta.
Simultaneous diameter and blood pressure registration is
essential for exact calculation of elastic parameters. Simul-
taneous diameter and pressure registration at the same aortic
site is impossible if elastic parameters are determined non-
invasively. However, close correlation of invasive and non-
invasive determination of AscAo distensibility has been
demonstrated.5 Nevertheless, aortic valve competence and
normal left ventricular systolic function are basic require-
ments for the interpretation of calculated aortic elastic pa-
rameters.
Several authors have shown decreased aortic distensibil-
ity and increased aortic stiffness index in patients with
MFS.6,7,12,21-25 Data obtained in children are rare.6,21 Our
results, which show a 50% reduced AscAo and a 30%
reduced DescAo distensibility in the MFS group, compare
ession models
Sensitivity (%) Specificity (%)
P value of
parameter(s)
63.2 84.2 .013
47.4 68.4 NS
84.2 68.4 .006
84.2 68.4 .002
73.3 78.8 .006
68.4 68.4 .003
52.6 47.4 NS
63.2 68.4 .027
73.7 57.9 .022
68.4 73.7 .021
52.6 57.9 NS
73.7 63.2 .007
63.2 68.4 NS
73.7 47.4 NS
eter; 94.7 100 .030; .028; .035
nd specificity. The P value describes the significance of each model’s
urface area (mm/m2).regr
diamwell to published data on children6 and young adults7,22
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Dwith MFS. Smaller values of mean aortic distensibility were
reported in older patients,24-27 and greater values were re-
ported in younger children.21 Our data confirm this depen-
dence of aortic distensibility on age. It is interesting to note
that the patients with normal diameters of the bulbus and the
AscAo also showed aortic dysfunction in terms of decreased
AscAo and DescAo distensibility. Therefore, assessment of
aortic dysfunction is of additional diagnostic value com-
pared with AscAo diameter measurements. The necessity of
-blocker therapy should be discussed in those patients.
MSAI is a further elastic parameter that is easy to deter-
mine, because blood pressure measurement is not required.
In our series, MSAI correlated very closely with aortic
distensibility. Follow-up investigations with the presented
elastic parameters could prove the efficiency of medical
treatment with, eg, -blocking agents and may be of help in
the timing of elective aortic surgery, especially in children
and adolescents not presenting with excessively dilated
aortic diameters that are unquestionably an indication for
elective prosthetic aortic root replacement. In our opinion,
an AscAo 0 distensibility can be regarded as additional
argument for elective aortic surgery. More detailed clinical
description was thought to be necessary to allow a geno-
type/phenotype correlation between patients described by
other groups28; our results in this relatively small MFS
group, however, did not reveal a dependence of aortic
distensibility on the type of FBN1 mutation (data not
shown). Objective data on aortic elastic properties, together
with the results of FBN1 gene mutation analysis of a greater
patient population, will perhaps show certain relationships.
Because FBN1 mutation analysis is still too expensive and
time-consuming to be used as screening tool, our logistic
regression models based on the results of only aortic pa-
rameters are an alternative approach to recognize and clas-
sify MFS. In patients with suspected MFS without aortic
dilatation, they can serve as useful additional diagnostic
tools to decide whether these patients should be genetically
tested. Our best multiple logistic regression model showed
higher sensitivity (94.7%) and specificity (100%) than the
best single logistic regression models (sensitivity and spec-
ificity of 68%-84%). This validated multiple logistic regres-
sion model can predict MFS more reliably than a cardio-
logic investigation including only aortic diameter
measurements (yielding a sensitivity of 89% in our popu-
lation and 61%-84% in published patient populations).1,13-16
It helps to decide about the necessity of time-consuming
follow-up investigations, especially in patients with low
suspicion of MFS and normal aortic elasticity, but does not
replace ophthalmologic and orthopedic investigations, be-
cause some rare patients with MFS show no aortic involve-
ment.14,17 Patients with Ehlers-Danlos syndrome type IV30
and thoracic aortic aneurysm2 may show reduced aortic
738 The Journal of Thoracic and Cardiovascular Surgery ● Aprielastic properties, too, and therefore may be investigated
with similar logistic regression models.
Conclusions
In summary, we determined decreased aortic elastic prop-
erties in young patients with MFS by a standardized semi-
automated image-segmentation technique that enables us to
estimate AscAo and DescAo distensibility, stiffness index,
and MSAI with high reproducibility. It also gives way to
high-quality follow-up investigations of aortic elastic prop-
erties in patients with suspected or confirmed MFS. Vec-
toraortography illustrates and the aortic integral ratio quan-
tifies the relationship of AscAo and DescAo elasticity and
so may show the region at risk for severe aortic complica-
tions. Our multiple logistic regression model enables us to
calculate the probability for the presence of MFS on the
basis of the results of solely aortic parameters (distensibil-
ity, normalized diastolic diameters of aortic bulbus, and
AscAo) and so can be used as a diagnostic tool with high
predictive power. Follow-up investigations in a larger pa-
tient population will prove the efficiency of medical treat-
ment and may determine the value of this method for the
prediction of aortic dissection and rupture, so these elastic
parameters may serve as additional criteria to indicate elec-
tive surgical intervention.
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